Nom du produit:N-{4-[6-(azepan-1-yl)pyridazin-3-yl]phenyl}-4-methoxy-2,5-dimethylbenzene-1-sulfonamide

IUPAC Name:N-{4-[6-(azepan-1-yl)pyridazin-3-yl]phenyl}-4-methoxy-2,5-dimethylbenzene-1-sulfonamide

CAS:946358-54-9
Formule moléculaire:C25H30N4O3S
Pureté:95%+
Numéro de catalogue:CM652895
Poids moléculaire:466.6

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:946358-54-9
Formule moléculaire:C25H30N4O3S
Point de fusion:-
Code SMILES:COC1=CC(C)=C(C=C1C)S(=O)(=O)NC1=CC=C(C=C1)C1=CC=C(N=N1)N1CCCCCC1
Densité:
Numéro de catalogue:CM652895
Poids moléculaire:466.6
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Azepanes
The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.